Quantumzyme Corp. Highlights Green Chemistry Innovations at Enzyme Engineering XXVIII Conference

Quantumzyme Corp. showcased its computational enzyme engineering platform and ibuprofen patent at the Enzyme Engineering XXVIII Conference, emphasizing its role in advancing sustainable pharmaceutical manufacturing.

Bay Area Metrowire Staff
Technology
Quantumzyme Corp. Highlights Green Chemistry Innovations at Enzyme Engineering XXVIII Conference

Quantumzyme Corp. (OTC: QTZM), a leader in computational enzyme engineering and green chemistry innovation, announced its participation in the Enzyme Engineering XXVIII Conference, held from September 15-19, 2025, in Helsingor, Denmark. The conference, organized by Engineering Conferences International (ECI), brought together leading scientists and industry pioneers to discuss advancements in enzyme design, biocatalysis, and synthetic biology.

Quantumzyme’s participation underscored its commitment to computational biocatalysis, showcasing innovations in enzyme-driven synthesis of active pharmaceutical ingredients (APIs). A key highlight was its recently published ibuprofen patent (US20250146029A1), which details a novel enzymatic pathway for producing ibuprofen, marking a milestone in eco-friendly pharmaceutical manufacturing. The company’s proprietary QZyme Workbench™ platform integrates quantum mechanics, artificial intelligence, and molecular modeling to design next-generation enzymes for diverse industrial applications.

Naveen Kulkarni, CEO of Quantumzyme Corp., stated that the event provided a tremendous opportunity to share the company’s vision and engage with global thought leaders. He noted that discussions and collaborations initiated during the event reinforce the mission to accelerate the adoption of sustainable biocatalytic solutions worldwide.

The conference served as a platform for sharing breakthroughs shaping the future of sustainable manufacturing and green chemistry. Quantumzyme’s involvement reflects its growing reputation as a key innovator in the field. For more information about the conference, visit ECI Enzyme Engineering XXVIII.

Quantumzyme Corp. is a pioneering biotransformation company revolutionizing chemical processes through sustainable, enzyme-based solutions. By integrating computational modeling with wet-lab validation, the company delivers scalable, cost-effective biocatalysis solutions that improve industrial sustainability. The company envisions a future where biotechnology drives global solutions for climate change, pollution, and resource efficiency.

Blockchain Registration

QR Code for Blockchain Registration